{"gene":"POMP","run_date":"2026-04-28T19:45:44","timeline":{"discoveries":[{"year":2000,"finding":"POMP (hUmp1) was identified as the human homologue of yeast Ump1 and shown to be present exclusively in 20S proteasome precursor complexes (16S intermediates) but not in mature 20S proteasomes, establishing its role as a transient assembly chaperone. POMP expression is induced by interferon-gamma. The beta5 propeptide is not essential for LMP7 incorporation in human cells (unlike yeast), but its deletion leads to delayed proteasome maturation and accumulation of POMP-containing precursor complexes.","method":"2D gel electrophoresis of precursor fractions, Northern blot, mutant LMP7 incorporation assays in T2 cells","journal":"Journal of molecular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (2D gel, Northern blot, functional incorporation assays), foundational characterization paper","pmids":["10926487"],"is_preprint":false},{"year":2007,"finding":"The main steps of mammalian 20S proteasome core complex formation take place at the endoplasmic reticulum (ER). POMP interacts with ER membranes, binds to alpha1-7 rings, recruits beta-subunits stepwise, and mediates the association of precursor complexes with the ER, coordinating the assembly process.","method":"Precursor complex-specific antibodies, subcellular fractionation, immunofluorescence, co-immunoprecipitation","journal":"EMBO reports","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (antibody-based fractionation, co-IP, localization) establishing ER as site of assembly with mechanistic detail","pmids":["17948026"],"is_preprint":false},{"year":2007,"finding":"In yeast, beta7 (Pre4) overproduction bypasses the requirement for the beta5 propeptide by a mechanism dependent on a unique beta7 C-terminal extension. Assembly proceeds stepwise through precursor dimers containing the Ump1 assembly factor and a Pba1-Pba2 complex. Ump1 enforces an assembly checkpoint; beta7 addition overcomes this checkpoint and stabilizes the precursor dimer to drive dimerization of two half-proteasomes.","method":"Genetic bypass/suppressor analysis, identification of assembly intermediates, biochemical fractionation, yeast genetics","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1-2 — genetic epistasis combined with biochemical fractionation of intermediates, highly cited foundational study","pmids":["17431397"],"is_preprint":false},{"year":2006,"finding":"POMP protein elutes from a calibrated gel-filtration column at approximately 64 kDa, suggesting tetramer formation. Immunofluorescence and confocal microscopy showed POMP localizes to both cytoplasm and nucleus.","method":"Gel filtration chromatography, immunofluorescence, confocal microscopy","journal":"International journal of biological macromolecules","confidence":"Medium","confidence_rationale":"Tier 3 — single lab, biochemical and imaging methods but no functional consequence tied to tetramerization","pmids":["16624403"],"is_preprint":false},{"year":2010,"finding":"A single-nucleotide deletion at position c.-95 in the POMP 5' UTR causes a transcriptional switch, markedly increasing POMP transcript variants with long 5' UTRs in keratinocytes. This is associated with altered epidermal distribution of POMP, proteasome subunits alpha7 and beta5, and ER stress marker CHOP, causing KLICK genodermatosis. These findings demonstrate a critical role for POMP-mediated proteasome assembly in terminal epidermal differentiation.","method":"SNP analysis, sequencing, Northern blot, immunohistochemistry, patient-derived keratinocytes","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — disease-causing mutation with mechanistic characterization via multiple methods in patient material","pmids":["20226437"],"is_preprint":false},{"year":2012,"finding":"siRNA silencing of POMP in epidermal air-liquid cultures caused aberrant proteasome subunit staining, perturbed profilaggrin-to-filaggrin processing, and activated the unfolded protein response (CHOP induction/ER stress), establishing that POMP is required for proteasome assembly in differentiating keratinocytes and that its loss leads to proteasome insufficiency and ER stress.","method":"siRNA knockdown, organotypic culture, immunohistochemistry, Western blot, CHOP induction assay","journal":"PloS one","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods in a disease-relevant in vitro model with defined molecular phenotype","pmids":["22235297"],"is_preprint":false},{"year":2013,"finding":"Yeast Ump1 is an intrinsically disordered protein (IDP) that lacks stable secondary structure in solution. Recombinant Ump1 forms oligomers mediated by intermolecular disulfide bonds through its single cysteine residue. The disordered nature may allow Ump1 to become structured only upon interaction with proteasome subunits.","method":"Recombinant protein expression, gel filtration, NMR, bioinformatics, biochemical analysis","journal":"Computational and structural biotechnology journal","confidence":"Medium","confidence_rationale":"Tier 1-2 — NMR and biochemical characterization, but functional consequence of IDP nature not directly tested","pmids":["24688736"],"is_preprint":false},{"year":2015,"finding":"miR-101 directly targets POMP, leading to impaired proteasome assembly and activity, accumulation of p53 and CDK inhibitors, cell cycle arrest, and apoptosis. miR-101-resistant POMP restores proteasome substrate turnover and tumor cell growth. POMP knockdown is sufficient to overcome bortezomib resistance in tumor cells, and suppressing POMP attenuates estrogen-driven transcription in ERα-positive breast cancers.","method":"miRNA overexpression, POMP knockdown, proteasome activity assays, cell cycle and apoptosis assays, bortezomib resistance rescue experiments","journal":"Molecular cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods (miRNA targeting, KD, rescue, activity assays) with defined molecular phenotypes in multiple cell lines","pmids":["26145175"],"is_preprint":false},{"year":2015,"finding":"POMP mutation combined with MCM3AP (GANP) mutation in an immunodeficient patient results in impaired NF-κB signaling after DNA damage. Complementation with wild-type POMP rescued defective NF-κB signaling, establishing that POMP-dependent proteasome assembly is required for efficient DNA damage-induced NF-κB signaling.","method":"Whole-exome sequencing, Sanger sequencing, complementation assay with wild-type POMP, patient-derived cell characterization","journal":"Human mutation","confidence":"Medium","confidence_rationale":"Tier 2 — functional complementation in patient cells, but single case/digenic context limits generalizability","pmids":["26615982"],"is_preprint":false},{"year":2017,"finding":"POMP binds to 20S proteasome precursor complexes and is overexpressed in lesional psoriatic skin. POMP silencing in HaCaT keratinocytes inhibited cell proliferation and induced apoptosis through inhibition of proteasome assembly, and also decreased expression of differentiation markers keratin 10 and involucrin during calcium-induced differentiation.","method":"Native gel electrophoresis, Western blot, IHC, qPCR, siRNA silencing, cell proliferation and apoptosis assays","journal":"Journal of dermatological science","confidence":"Medium","confidence_rationale":"Tier 2-3 — co-IP/native gel plus functional KD with specific cellular phenotypes in a relevant cell line","pmids":["28728908"],"is_preprint":false},{"year":2018,"finding":"Heterozygous frameshift variants in the penultimate exon of POMP escape nonsense-mediated mRNA decay (NMD) and produce a truncated protein that perturbs proteasome assembly by a dominant-negative mechanism, causing PRAID (POMP-related autoinflammation and immune dysregulation disease) with early-onset combined immunodeficiency, inflammatory neutrophilic dermatosis, and autoimmunity.","method":"Whole-exome sequencing, NMD assay, proteasome assembly analysis, patient cell characterization, biochemical analysis of truncated protein","journal":"American journal of human genetics","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including NMD escape demonstration, proteasome assembly perturbation, and patient phenotyping","pmids":["29805043"],"is_preprint":false},{"year":2020,"finding":"NRF3 transcription factor directly induces POMP gene expression in cancer cells, upregulating 20S proteasome assembly. The NRF3-POMP axis promotes ubiquitin-independent proteolysis of tumor suppressors p53 and Rb by the 20S proteasome, supporting colorectal cancer development and metastasis, and conferring impaired sensitivity to bortezomib (but not to E1 inhibitor TAK-243).","method":"NRF3 knockdown, POMP overexpression/knockdown, reporter assays, protein stability assays with proteasome inhibitors, ChIP, cell viability and tumorigenesis assays","journal":"Molecular and cellular biology","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods establishing transcriptional regulation of POMP by NRF3 and functional consequences for 20S-dependent proteolysis","pmids":["32123008"],"is_preprint":false},{"year":2022,"finding":"An N-terminal domain of yeast Ump1 (first 16 residues) and the propeptide of beta7 promote direct interaction of the two proteins in vitro. This interaction is critical for recruitment of beta7 precursor during proteasome assembly, a step that drives dimerization of 15S half-proteasome precursor complexes and formation of mature 20S core particles. Deletion of the first 16 Ump1 residues causes accumulation of 15S PC intermediates and requires Rpn4-dependent transcription for viability, which is rescued by beta7 overexpression.","method":"In vitro binding assay, mutational analysis of Ump1 and beta7, yeast genetics (epistasis, rescue), native gel analysis of intermediates","journal":"Biomolecules","confidence":"High","confidence_rationale":"Tier 1-2 — in vitro reconstitution of direct binding combined with genetic epistasis and biochemical intermediate analysis","pmids":["35204754"],"is_preprint":false},{"year":2025,"finding":"Upon proteasome disruption, POMP rapidly accumulates in the nucleolus in a manner dependent on HSF1 and reactive oxygen species (ROS). Proteomic analysis reveals POMP interacts with RNA processing factors in this context, and transcriptomic profiling shows nucleolar POMP orchestrates a protective transcriptional program, revealing a moonlighting role as a stress-induced transcriptional regulator beyond its canonical chaperone function. This mechanism is developmentally controlled and active in neurodegenerative disease contexts.","method":"Live-cell imaging, proteomic interactor analysis, transcriptomic profiling, HSF1/ROS perturbation experiments","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — multiple orthogonal methods (imaging, proteomics, transcriptomics) but preprint with no peer review yet","pmids":["bio_10.1101_2025.04.25.650603"],"is_preprint":true},{"year":2024,"finding":"Cryo-EM structural analysis of human 20S proteasome biogenesis revealed: PAC1-4 stabilize an early alpha-ring intermediate; PAC3/PAC4 dissociation and PAC1 N-terminal tail rearrangement trigger beta-ring assembly; completion of the beta-ring and half-proteasome dimerization repositions lysine K33 to trigger cleavage of beta propeptides, leading to concerted dissociation of POMP and PAC1/PAC2 to yield mature 20S proteasomes.","method":"CRISPR/Cas9 endogenous tagging of chaperones, cryo-EM structural analysis of chaperone-bound complexes","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 1 — cryo-EM with endogenous tagging providing high-resolution structural mechanism, but preprint awaiting peer review","pmids":["bio_10.1101_2024.08.08.607236"],"is_preprint":true},{"year":2007,"finding":"Overexpression of hUMP1/POMP in human fibroblasts increases levels of functional proteasome and enhances cellular capacity to cope with oxidative stressors, demonstrating that POMP-mediated proteasome assembly upregulation is sufficient to enhance antioxidant defense.","method":"Stable overexpression in fibroblasts, proteasome activity assays, oxidative stress survival assays","journal":"Experimental gerontology","confidence":"Medium","confidence_rationale":"Tier 2-3 — functional overexpression with defined proteasome activity and stress-resistance phenotype in human cells","pmids":["17349762"],"is_preprint":false},{"year":2025,"finding":"CRISPR-generated pomp mutant zebrafish embryos display defects in myocardial cell shapes and outflow tract development, establishing a critical role for POMP in heart development. These cardiac phenotypes resemble those of other zebrafish congenital heart defect gene mutants.","method":"CRISPR mutagenesis in zebrafish, phenotypic analysis of heart morphology (myocardial cell shape, outflow tract)","journal":"bioRxiv","confidence":"Medium","confidence_rationale":"Tier 2 — CRISPR loss-of-function in a vertebrate model organism with specific cardiac phenotype readout, but preprint","pmids":["bio_10.1101_2025.01.16.633339"],"is_preprint":true}],"current_model":"POMP (proteasome maturation protein, human homologue of yeast Ump1) is a transiently acting, intrinsically disordered assembly chaperone that binds alpha-rings at the endoplasmic reticulum, recruits beta-subunits stepwise into 15S half-proteasome precursor complexes, directly interacts via its N-terminal domain with the beta7 propeptide to drive half-proteasome dimerization, and is then degraded upon autocatalytic activation of the nascent 20S core; its expression is induced by interferon-gamma and the transcription factor NRF3, regulated post-transcriptionally by miR-101, and loss-of-function or dominant-negative mutations cause proteasome insufficiency linked to skin disorders (KLICK), autoinflammatory immunodeficiency (PRAID), and impaired NF-κB signaling, while a newly discovered moonlighting role involves stress-induced nucleolar accumulation where POMP orchestrates a protective transcriptional program via HSF1 and ROS-dependent mechanisms."},"narrative":{"teleology":[{"year":2000,"claim":"Identification of POMP as the human Ump1 orthologue present exclusively in proteasome precursor complexes established that 20S assembly requires a dedicated, transient chaperone induced by interferon-gamma.","evidence":"2D gel electrophoresis of precursor fractions, Northern blot, and mutant LMP7 incorporation assays in T2 cells","pmids":["10926487"],"confidence":"High","gaps":["Structural basis of POMP–precursor interaction unknown","Subcellular site of assembly not determined","Mechanism of POMP degradation upon maturation unclear"]},{"year":2007,"claim":"Localization of proteasome assembly to the endoplasmic reticulum resolved where POMP orchestrates the stepwise recruitment of beta-subunits onto alpha-rings, and yeast genetics revealed that Ump1 enforces an assembly checkpoint overcome by beta7 addition to drive half-proteasome dimerization.","evidence":"Subcellular fractionation, co-IP, and immunofluorescence in mammalian cells; genetic bypass/suppressor analysis and biochemical fractionation of assembly intermediates in yeast","pmids":["17948026","17431397"],"confidence":"High","gaps":["Direct POMP–beta7 interaction not demonstrated in vitro","Structural intermediates not resolved at high resolution","Role of PAC1-4 co-chaperones in relation to POMP not fully delineated"]},{"year":2007,"claim":"Overexpression of POMP in human fibroblasts proved sufficient to increase functional proteasome levels and enhance resistance to oxidative stress, establishing POMP as a rate-limiting factor in proteasome biogenesis with physiological consequences.","evidence":"Stable overexpression, proteasome activity assays, and oxidative stress survival assays in human fibroblasts","pmids":["17349762"],"confidence":"Medium","gaps":["Whether endogenous POMP levels are limiting in vivo not addressed","No in vivo animal model tested"]},{"year":2010,"claim":"Discovery that a 5′ UTR mutation in POMP causes KLICK genodermatosis linked proteasome assembly deficiency to a human Mendelian skin disease and revealed the sensitivity of terminal epidermal differentiation to POMP dosage.","evidence":"SNP analysis, Northern blot, immunohistochemistry, and analysis of patient-derived keratinocytes","pmids":["20226437"],"confidence":"High","gaps":["Precise mechanism by which 5′ UTR shift reduces functional POMP protein not fully resolved","No rescue experiment in patient cells reported"]},{"year":2012,"claim":"siRNA silencing of POMP in organotypic epidermal cultures demonstrated that loss of proteasome assembly causes ER stress, defective profilaggrin processing, and unfolded protein response activation, providing a mechanistic basis for KLICK pathology.","evidence":"siRNA knockdown in air-liquid interface keratinocyte cultures, immunohistochemistry, Western blot, CHOP induction assay","pmids":["22235297"],"confidence":"High","gaps":["Specific proteasome substrates accumulating in POMP-deficient epidermis not catalogued","Contribution of immunoproteasome versus constitutive proteasome not distinguished"]},{"year":2013,"claim":"Biophysical characterization of yeast Ump1 as an intrinsically disordered protein suggested that POMP-family chaperones acquire structure only upon engagement with proteasome subunits, rationalizing their transient incorporation.","evidence":"Recombinant protein NMR, gel filtration, and bioinformatics","pmids":["24688736"],"confidence":"Medium","gaps":["No direct evidence that human POMP is similarly disordered","Functional consequence of IDP nature not tested by mutagenesis"]},{"year":2015,"claim":"Identification of miR-101 as a direct post-transcriptional repressor of POMP revealed that POMP levels are rate-limiting for tumor cell proteasome capacity, and that POMP knockdown is sufficient to overcome bortezomib resistance.","evidence":"miRNA overexpression, POMP knockdown and miR-101-resistant rescue, proteasome activity assays, bortezomib resistance experiments in multiple cell lines","pmids":["26145175"],"confidence":"High","gaps":["In vivo relevance of miR-101–POMP axis in tumors not demonstrated","Whether other miRNAs converge on POMP not explored"]},{"year":2015,"claim":"A patient POMP mutation combined with MCM3AP deficiency showed that POMP-dependent proteasome assembly is required for DNA damage-induced NF-κB signaling, extending POMP's functional reach beyond proteostasis to immune signaling.","evidence":"Whole-exome sequencing, complementation with wild-type POMP in patient-derived cells","pmids":["26615982"],"confidence":"Medium","gaps":["Digenic context complicates attribution of phenotype to POMP alone","Single patient—generalizability uncertain"]},{"year":2018,"claim":"Dominant-negative POMP frameshift variants that escape NMD were shown to poison proteasome assembly, causing PRAID—a syndromic autoinflammatory immunodeficiency—demonstrating that truncated POMP actively disrupts the assembly pathway.","evidence":"Whole-exome sequencing, NMD escape assay, proteasome assembly analysis, patient cell characterization","pmids":["29805043"],"confidence":"High","gaps":["Structural basis of dominant-negative interference not determined","Whether haploinsufficiency alone is pathogenic not resolved"]},{"year":2020,"claim":"NRF3 was identified as a direct transcriptional activator of POMP in cancer cells, showing that the NRF3–POMP axis promotes ubiquitin-independent 20S-mediated degradation of p53 and Rb to drive colorectal tumorigenesis.","evidence":"ChIP, reporter assays, knockdown/overexpression, protein stability assays with proteasome and E1 inhibitors, tumorigenesis assays","pmids":["32123008"],"confidence":"High","gaps":["Whether NRF3–POMP axis operates in non-cancer tissues not addressed","Structural selectivity of 20S for disordered tumor suppressors not mechanistically resolved"]},{"year":2022,"claim":"In vitro reconstitution demonstrated that the N-terminal 16 residues of Ump1 directly bind the beta7 propeptide, identifying the minimal interaction that triggers half-proteasome dimerization and providing the first direct binding evidence for this critical assembly step.","evidence":"In vitro binding assays, Ump1 and beta7 deletion mutants, yeast genetic rescue, native gel analysis of assembly intermediates","pmids":["35204754"],"confidence":"High","gaps":["No equivalent binding data for human POMP–beta7","Atomic-resolution structure of the POMP–beta7 interface lacking"]},{"year":null,"claim":"Key open questions include the high-resolution structural basis of POMP within mammalian half-proteasome precursors, the mechanism of its concerted degradation upon 20S maturation, in vivo validation of its reported nucleolar stress-sensing role, and whether its cardiac developmental function reflects proteasome-dependent or moonlighting activity.","evidence":"","pmids":[],"confidence":"Low","gaps":["No published atomic-resolution structure of human POMP bound to assembly intermediates (cryo-EM preprint awaits peer review)","Mechanism of POMP degradation upon 20S maturation not reconstituted","Nucleolar moonlighting role reported only in a preprint"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0044183","term_label":"protein folding chaperone","supporting_discovery_ids":[0,1,2,6,12]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[0,2,12]}],"localization":[{"term_id":"GO:0005783","term_label":"endoplasmic reticulum","supporting_discovery_ids":[1]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[3]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[3]}],"pathway":[{"term_id":"R-HSA-392499","term_label":"Metabolism of proteins","supporting_discovery_ids":[0,1,2,5,12]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[5,15]},{"term_id":"R-HSA-168256","term_label":"Immune System","supporting_discovery_ids":[8,10]},{"term_id":"R-HSA-1643685","term_label":"Disease","supporting_discovery_ids":[4,10]}],"complexes":["15S half-proteasome precursor complex","20S proteasome precursor (16S intermediate)"],"partners":["PSMA7","PSMB5","PSMB7","PAC1","PAC2","NRF3","HSF1"],"other_free_text":[]},"mechanistic_narrative":"POMP is an intrinsically disordered, transiently acting assembly chaperone essential for biogenesis of the 20S proteasome core particle. It associates with alpha-rings at the endoplasmic reticulum, recruits beta-subunits stepwise into half-proteasome precursor complexes, and directly engages the beta7 propeptide via its N-terminal domain to drive half-proteasome dimerization, after which it is degraded upon autocatalytic maturation of the nascent 20S particle [PMID:10926487, PMID:17948026, PMID:35204754]. Its expression is induced by interferon-gamma and the transcription factor NRF3, and is post-transcriptionally repressed by miR-101; loss of POMP causes proteasome insufficiency, ER stress, and impaired NF-κB signaling, while dominant-negative truncating variants escaping NMD cause PRAID (POMP-related autoinflammation and immune dysregulation) and a 5′ UTR mutation causes the keratinization disorder KLICK [PMID:20226437, PMID:29805043, PMID:26145175, PMID:32123008]. POMP overexpression is sufficient to increase functional proteasome levels and enhance cellular resistance to oxidative stress [PMID:17349762]."},"prefetch_data":{"uniprot":{"accession":"Q9Y244","full_name":"Proteasome maturation protein","aliases":["Proteassemblin","Protein UMP1 homolog","hUMP1","Voltage-gated K channel beta subunit 4.1"],"length_aa":141,"mass_kda":15.8,"function":"Molecular chaperone essential for the assembly of standard proteasomes and immunoproteasomes. Degraded after completion of proteasome maturation. Mediates the association of 20S preproteasome with the endoplasmic reticulum","subcellular_location":"Cytoplasm, cytosol; Nucleus; Microsome membrane","url":"https://www.uniprot.org/uniprotkb/Q9Y244/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":true,"resolved_as":"","url":"https://depmap.org/portal/gene/POMP","classification":"Common Essential","n_dependent_lines":567,"n_total_lines":1208,"dependency_fraction":0.4693708609271523},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[{"gene":"PSMB3","stoichiometry":10.0},{"gene":"PSMG1","stoichiometry":10.0},{"gene":"PSMG2","stoichiometry":10.0},{"gene":"PSMG4","stoichiometry":10.0},{"gene":"PSMA1","stoichiometry":4.0},{"gene":"PSMB7","stoichiometry":4.0},{"gene":"PSMA5","stoichiometry":0.2},{"gene":"PSMA6","stoichiometry":0.2},{"gene":"PSMB1","stoichiometry":0.2},{"gene":"PSMB2","stoichiometry":0.2}],"url":"https://opencell.sf.czbiohub.org/search/POMP","total_profiled":1310},"omim":[{"mim_id":"619452","title":"ANENCEPHALY 2; ANPH2","url":"https://www.omim.org/entry/619452"},{"mim_id":"618048","title":"PROTEASOME-ASSOCIATED AUTOINFLAMMATORY SYNDROME 2; PRAAS2","url":"https://www.omim.org/entry/618048"},{"mim_id":"616406","title":"PYRROLINE-5-CARBOXYLATE REDUCTASE 2; PYCR2","url":"https://www.omim.org/entry/616406"},{"mim_id":"616212","title":"LISSENCEPHALY 6 WITH MICROCEPHALY; LIS6","url":"https://www.omim.org/entry/616212"},{"mim_id":"613386","title":"PROTEASOME MATURATION PROTEIN; POMP","url":"https://www.omim.org/entry/613386"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Nuclear speckles","reliability":"Supported"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/POMP"},"hgnc":{"alias_symbol":["HSPC014","UMP1"],"prev_symbol":["C13orf12"]},"alphafold":{"accession":"Q9Y244","domains":[{"cath_id":"-","chopping":"91-141","consensus_level":"medium","plddt":87.9343,"start":91,"end":141}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y244","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y244-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q9Y244-F1-predicted_aligned_error_v6.png","plddt_mean":81.0},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=POMP","jax_strain_url":"https://www.jax.org/strain/search?query=POMP"},"sequence":{"accession":"Q9Y244","fasta_url":"https://rest.uniprot.org/uniprotkb/Q9Y244.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q9Y244/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q9Y244"}},"corpus_meta":[{"pmid":"17431397","id":"PMC_17431397","title":"beta-Subunit appendages promote 20S proteasome assembly by overcoming an Ump1-dependent checkpoint.","date":"2007","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/17431397","citation_count":133,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"29805043","id":"PMC_29805043","title":"Heterozygous Truncating Variants in POMP Escape Nonsense-Mediated Decay and Cause a Unique Immune Dysregulatory Syndrome.","date":"2018","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/29805043","citation_count":126,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10926487","id":"PMC_10926487","title":"Characterisation of the newly identified human Ump1 homologue POMP and analysis of LMP7(beta 5i) incorporation into 20 S proteasomes.","date":"2000","source":"Journal of molecular biology","url":"https://pubmed.ncbi.nlm.nih.gov/10926487","citation_count":103,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35157496","id":"PMC_35157496","title":"SWOG 1318: A Phase II Trial of Blinatumomab Followed by POMP Maintenance in Older Patients With Newly Diagnosed Philadelphia Chromosome-Negative B-Cell Acute Lymphoblastic Leukemia.","date":"2022","source":"Journal of clinical oncology : official journal of the American Society of Clinical Oncology","url":"https://pubmed.ncbi.nlm.nih.gov/35157496","citation_count":95,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17948026","id":"PMC_17948026","title":"The proteasome maturation protein POMP facilitates major steps of 20S proteasome formation at the endoplasmic reticulum.","date":"2007","source":"EMBO reports","url":"https://pubmed.ncbi.nlm.nih.gov/17948026","citation_count":90,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16337885","id":"PMC_16337885","title":"Ump1 extends yeast lifespan and enhances viability during oxidative stress: central role for the proteasome?","date":"2005","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/16337885","citation_count":69,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26145175","id":"PMC_26145175","title":"MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26145175","citation_count":63,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"20226437","id":"PMC_20226437","title":"A single-nucleotide deletion in the POMP 5' UTR causes a transcriptional switch and altered epidermal proteasome distribution in KLICK genodermatosis.","date":"2010","source":"American journal of human genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20226437","citation_count":62,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17349762","id":"PMC_17349762","title":"Overexpression of hUMP1/POMP proteasome accessory protein enhances proteasome-mediated antioxidant defence.","date":"2007","source":"Experimental gerontology","url":"https://pubmed.ncbi.nlm.nih.gov/17349762","citation_count":50,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32123008","id":"PMC_32123008","title":"NRF3-POMP-20S Proteasome Assembly Axis Promotes Cancer Development via Ubiquitin-Independent Proteolysis of p53 and Retinoblastoma Protein.","date":"2020","source":"Molecular and cellular biology","url":"https://pubmed.ncbi.nlm.nih.gov/32123008","citation_count":39,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"15607905","id":"PMC_15607905","title":"RNA interference toward UMP1 induces proteasome inhibition in Saccharomyces cerevisiae: evidence for protein oxidation and autophagic cell death.","date":"2005","source":"Free radical biology & medicine","url":"https://pubmed.ncbi.nlm.nih.gov/15607905","citation_count":28,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24688736","id":"PMC_24688736","title":"Biochemical and biophysical characterization of recombinant yeast proteasome maturation factor ump1.","date":"2013","source":"Computational and structural biotechnology journal","url":"https://pubmed.ncbi.nlm.nih.gov/24688736","citation_count":23,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"1060502","id":"PMC_1060502","title":"Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen).","date":"1975","source":"British medical journal","url":"https://pubmed.ncbi.nlm.nih.gov/1060502","citation_count":22,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26615982","id":"PMC_26615982","title":"MCM3AP and POMP Mutations Cause a DNA-Repair and DNA-Damage-Signaling Defect in an Immunodeficient Child.","date":"2015","source":"Human mutation","url":"https://pubmed.ncbi.nlm.nih.gov/26615982","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"22235297","id":"PMC_22235297","title":"siRNA silencing of proteasome maturation protein (POMP) activates the unfolded protein response and constitutes a model for KLICK genodermatosis.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22235297","citation_count":20,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"16624403","id":"PMC_16624403","title":"Possible tetramerisation of the proteasome maturation factor POMP/proteassemblin/hUmp1 and its subcellular localisation.","date":"2006","source":"International journal of biological macromolecules","url":"https://pubmed.ncbi.nlm.nih.gov/16624403","citation_count":18,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24065419","id":"PMC_24065419","title":"Backbone ¹H, ¹³C and ¹⁵N assignments of yeast Ump1, an intrinsically disordered protein that functions as a proteasome assembly chaperone.","date":"2013","source":"Biomolecular NMR assignments","url":"https://pubmed.ncbi.nlm.nih.gov/24065419","citation_count":16,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10975253","id":"PMC_10975253","title":"Expression of UMP1 is inducible by DNA damage and required for resistance of S. cerevisiae cells to UV light.","date":"2000","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10975253","citation_count":15,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"28728908","id":"PMC_28728908","title":"The proteasome maturation protein POMP increases proteasome assembly and activity in psoriatic lesional skin.","date":"2017","source":"Journal of dermatological science","url":"https://pubmed.ncbi.nlm.nih.gov/28728908","citation_count":12,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"37914724","id":"PMC_37914724","title":"Regulation of symbiotic interactions and primitive lichen differentiation by UMP1 MAP kinase in Umbilicaria muhlenbergii.","date":"2023","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/37914724","citation_count":11,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"10757750","id":"PMC_10757750","title":"Proteasome mutants, pre4-2 and ump1-2, suppress the essential function but not the mitochondrial RNase P function of the Saccharomyces cerevisiae gene RPM2.","date":"2000","source":"Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/10757750","citation_count":10,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"17909815","id":"PMC_17909815","title":"The spectrum of spontaneous mutations caused by deficiency in proteasome maturase Ump1 in Saccharomyces cerevisiae.","date":"2007","source":"Current genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17909815","citation_count":9,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"32425927","id":"PMC_32425927","title":"KLICK Syndrome Linked to a POMP Mutation Has Features Suggestive of an Autoinflammatory Keratinization Disease.","date":"2020","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/32425927","citation_count":8,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"35204754","id":"PMC_35204754","title":"Interaction with the Assembly Chaperone Ump1 Promotes Incorporation of the β7 Subunit into Half-Proteasome Precursor Complexes Driving Their Dimerization.","date":"2022","source":"Biomolecules","url":"https://pubmed.ncbi.nlm.nih.gov/35204754","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26186288","id":"PMC_26186288","title":"Blocking Cancer Growth with Less POMP or Proteasomes.","date":"2015","source":"Molecular cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186288","citation_count":6,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"30957645","id":"PMC_30957645","title":"Expression analysis of proteasome maturation protein (POMP) gene in Liaoning Cashmere goat.","date":"2019","source":"Animal biotechnology","url":"https://pubmed.ncbi.nlm.nih.gov/30957645","citation_count":3,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"24693675","id":"PMC_24693675","title":"Effect of proton pomp inhibitor (PPI : Rabeprazole) on reflux esophagitis after endoscopic injection sclerotherapy (EIS), a randomized control study (24 hour-pH monitoring).","date":"2013","source":"Fukuoka igaku zasshi = Hukuoka acta medica","url":"https://pubmed.ncbi.nlm.nih.gov/24693675","citation_count":2,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"34557276","id":"PMC_34557276","title":"Phylogenetic and molecular analysis based on genes 16S-rRNA, OMPA and POMP to identify Chlamydia abortus infection occurrence at the milk samples of goats and sheep in west Azerbaijan of Iran.","date":"2021","source":"Iranian journal of microbiology","url":"https://pubmed.ncbi.nlm.nih.gov/34557276","citation_count":1,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":"26165073","id":"PMC_26165073","title":"[Effect of H2-receptor antagonist and proton pomp inhibitor on the treatment of acid-related disease].","date":"2015","source":"Nihon rinsho. Japanese journal of clinical medicine","url":"https://pubmed.ncbi.nlm.nih.gov/26165073","citation_count":0,"is_preprint":false,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.08.13.670186","title":"A recombinant expression system for the <i>Plasmodium falciparum</i> proteasome enables structural analysis of its assembly and the design of selective inhibitors","date":"2025-08-14","source":"bioRxiv","url":"https://doi.org/10.1101/2025.08.13.670186","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.04.25.650603","title":"The proteasome maturation factor POMP moonlights as a stress-induced transcriptional regulator","date":"2025-04-27","source":"bioRxiv","url":"https://doi.org/10.1101/2025.04.25.650603","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.10.04.25337267","title":"A Hybrid Deep Learning-Mechanistic Modeling Framework for Dengue Transmission Dynamics in Guangdong, China","date":"2025-10-07","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.04.25337267","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2025.01.16.633339","title":"A systems genetics approach identifies roles for proteasome factors in heart development and congenital heart defects","date":"2025-01-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.01.16.633339","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":null,"id":"bio_10.1101_2024.08.08.607236","title":"Structural basis of human 20S proteasome biogenesis","date":"2024-08-08","source":"bioRxiv","url":"https://doi.org/10.1101/2024.08.08.607236","citation_count":0,"is_preprint":true,"source_track":"pubmed_title"},{"pmid":"21478870","id":"PMC_21478870","title":"A diverse range of gene products are effectors of the type I interferon antiviral response.","date":"2011","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/21478870","citation_count":2031,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"12477932","id":"PMC_12477932","title":"Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences.","date":"2002","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/12477932","citation_count":1479,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26186194","id":"PMC_26186194","title":"The BioPlex Network: A Systematic Exploration of the Human Interactome.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26186194","citation_count":1118,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"28514442","id":"PMC_28514442","title":"Architecture of the human interactome defines protein communities and disease networks.","date":"2017","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/28514442","citation_count":1085,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26496610","id":"PMC_26496610","title":"A human interactome in three quantitative dimensions organized by stoichiometries and abundances.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/26496610","citation_count":1015,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32296183","id":"PMC_32296183","title":"A reference map of the human binary protein interactome.","date":"2020","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/32296183","citation_count":849,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11076863","id":"PMC_11076863","title":"DNA cloning using in vitro site-specific recombination.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11076863","citation_count":815,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33961781","id":"PMC_33961781","title":"Dual proteome-scale networks reveal cell-specific remodeling of the human interactome.","date":"2021","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/33961781","citation_count":705,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21873635","id":"PMC_21873635","title":"Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium.","date":"2011","source":"Briefings in bioinformatics","url":"https://pubmed.ncbi.nlm.nih.gov/21873635","citation_count":656,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"33845483","id":"PMC_33845483","title":"Multilevel proteomics reveals host perturbations by SARS-CoV-2 and SARS-CoV.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/33845483","citation_count":532,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"25910212","id":"PMC_25910212","title":"Widespread macromolecular interaction perturbations in human genetic disorders.","date":"2015","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/25910212","citation_count":454,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"15489334","id":"PMC_15489334","title":"The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).","date":"2004","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/15489334","citation_count":438,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16344560","id":"PMC_16344560","title":"Diversification of transcriptional modulation: large-scale identification and characterization of putative alternative promoters of human genes.","date":"2005","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/16344560","citation_count":409,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"8889549","id":"PMC_8889549","title":"Generation and analysis of 280,000 human expressed sequence tags.","date":"1996","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/8889549","citation_count":376,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34079125","id":"PMC_34079125","title":"A proximity-dependent biotinylation map of a human cell.","date":"2021","source":"Nature","url":"https://pubmed.ncbi.nlm.nih.gov/34079125","citation_count":339,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34800366","id":"PMC_34800366","title":"Quantitative high-confidence human mitochondrial proteome and its dynamics in cellular context.","date":"2021","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/34800366","citation_count":239,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"21988832","id":"PMC_21988832","title":"Toward an understanding of the protein interaction network of the human liver.","date":"2011","source":"Molecular systems biology","url":"https://pubmed.ncbi.nlm.nih.gov/21988832","citation_count":207,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11042152","id":"PMC_11042152","title":"Cloning and functional analysis of cDNAs with open reading frames for 300 previously undefined genes expressed in CD34+ hematopoietic stem/progenitor cells.","date":"2000","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11042152","citation_count":161,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"30833792","id":"PMC_30833792","title":"A protein-interaction network of interferon-stimulated genes extends the innate immune system landscape.","date":"2019","source":"Nature immunology","url":"https://pubmed.ncbi.nlm.nih.gov/30833792","citation_count":159,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11230166","id":"PMC_11230166","title":"Toward a catalog of human genes and proteins: sequencing and analysis of 500 novel complete protein coding human cDNAs.","date":"2001","source":"Genome research","url":"https://pubmed.ncbi.nlm.nih.gov/11230166","citation_count":151,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"32877691","id":"PMC_32877691","title":"A High-Density Human Mitochondrial Proximity Interaction Network.","date":"2020","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/32877691","citation_count":148,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26972000","id":"PMC_26972000","title":"Substrate-Trapped Interactors of PHD3 and FIH Cluster in Distinct Signaling Pathways.","date":"2016","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/26972000","citation_count":77,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"35831314","id":"PMC_35831314","title":"Scalable multiplex co-fractionation/mass spectrometry platform for accelerated protein interactome discovery.","date":"2022","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/35831314","citation_count":65,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"23824909","id":"PMC_23824909","title":"Bcl2-associated athanogene 3 interactome analysis reveals a new role in modulating proteasome activity.","date":"2013","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/23824909","citation_count":63,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"34732716","id":"PMC_34732716","title":"Competitive binding of E3 ligases TRIM26 and WWP2 controls SOX2 in glioblastoma.","date":"2021","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/34732716","citation_count":51,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"9428647","id":"PMC_9428647","title":"Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides.","date":"1997","source":"FEBS letters","url":"https://pubmed.ncbi.nlm.nih.gov/9428647","citation_count":48,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"31073040","id":"PMC_31073040","title":"LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling.","date":"2019","source":"Science (New York, N.Y.)","url":"https://pubmed.ncbi.nlm.nih.gov/31073040","citation_count":47,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"16712791","id":"PMC_16712791","title":"Identification of intrahepatic cholangiocarcinoma related genes by comparison with normal liver tissues using expressed sequence tags.","date":"2006","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/16712791","citation_count":45,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"11369620","id":"PMC_11369620","title":"Genetic basis of hemolytic anemia caused by pyrimidine 5' nucleotidase deficiency.","date":"2001","source":"Blood","url":"https://pubmed.ncbi.nlm.nih.gov/11369620","citation_count":42,"is_preprint":false,"source_track":"gene2pubmed"},{"pmid":"26288249","id":"PMC_26288249","title":"Variability of Gene Expression Identifies Transcriptional Regulators of Early Human Embryonic Development.","date":"2015","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/26288249","citation_count":42,"is_preprint":false,"source_track":"gene2pubmed"}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":16870,"output_tokens":4218,"usd":0.05694},"stage2":{"model":"claude-opus-4-6","input_tokens":7680,"output_tokens":3216,"usd":0.1782},"total_usd":0.480552,"stage1_batch_id":"msgbatch_01SUR8NDzVrNmyszWyJeCct7","stage2_batch_id":"msgbatch_01G7Yfutko3cDWzejrwH5AMx","note":"batch pricing = 50% of standard","round2_stage1":{"model":"claude-sonnet-4-6","input_tokens":29313,"output_tokens":4345,"usd":0.076557},"round2_rules_fired":"R3","round2_stage2":{"model":"claude-opus-4-6","input_tokens":8029,"output_tokens":2897,"usd":0.168855}},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"POMP (hUmp1) was identified as the human homologue of yeast Ump1 and shown to be present only in 20S proteasome precursor complexes (not mature 20S), indicating its role as an assembly chaperone that is degraded upon maturation. POMP expression is induced by interferon-gamma. The beta5 propeptide is not essential for LMP7 incorporation in human cells, unlike yeast, but its absence leads to delayed proteasome maturation and accumulation of POMP-containing precursor complexes.\",\n      \"method\": \"2D gel analysis of 16S precursor preparations, Northern blot, cell fractionation, mutant LMP7 incorporation assays in human T2 cells\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal fractionation plus functional mutagenesis, foundational identification paper\",\n      \"pmids\": [\"10926487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In yeast, beta7 (Pre4) incorporation into the proteasome occurs late in assembly and is closely linked to dimerization of two half-proteasome precursor complexes. Ump1 (POMP orthologue) establishes an assembly checkpoint: the beta5 propeptide normally drives dimerization, but overproduction of beta7 (via its unique C-terminal extension contacting the opposing beta ring) can bypass the Ump1-dependent checkpoint. Assembly proceeds stepwise through precursor dimers containing Ump1 and the Pba1-Pba2 complex.\",\n      \"method\": \"Genetic bypass suppressor analysis, identification of assembly intermediates, co-purification of Ump1 and Pba1-Pba2 with precursor complexes\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genetic epistasis plus biochemical intermediate isolation, highly cited foundational study\",\n      \"pmids\": [\"17431397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"POMP facilitates the main steps of mammalian 20S proteasome core complex formation at the endoplasmic reticulum (ER). POMP interacts with ER membranes, binds to alpha1-7 rings, recruits beta-subunits stepwise, and mediates association of precursor complexes with the ER.\",\n      \"method\": \"Precursor complex-specific antibodies, subcellular fractionation, co-immunoprecipitation, live-cell imaging\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — direct localization with functional consequence, multiple orthogonal methods\",\n      \"pmids\": [\"17948026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A single-nucleotide deletion in the POMP 5' UTR causes a transcriptional switch to longer transcript variants, resulting in altered epidermal distribution of POMP and proteasome subunits (alpha7, beta5) and ER stress (CHOP marker accumulation) in KLICK genodermatosis patient skin, establishing POMP's critical role in terminal epidermal differentiation.\",\n      \"method\": \"SNP mapping, Sanger sequencing, immunohistochemistry of patient skin biopsies, transcript analysis\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — patient-derived tissue with mechanistic follow-up, single lab\",\n      \"pmids\": [\"20226437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"siRNA knockdown of POMP in epidermal organotypic cultures leads to decreased proteasome subunit levels, aberrant profilaggrin-to-filaggrin processing, and activation of the unfolded protein response (UPR/ER stress, CHOP induction), demonstrating that POMP-mediated proteasome assembly is required for normal keratinocyte differentiation.\",\n      \"method\": \"siRNA knockdown, organotypic air-liquid interface cultures, immunohistochemistry, western blot, UPR marker analysis\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with defined cellular and molecular phenotype, multiple readouts\",\n      \"pmids\": [\"22235297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-101 directly targets the POMP 3' UTR, reducing POMP protein levels, which impairs 20S proteasome assembly and activity, leading to accumulation of p53 and CDK inhibitors, cell cycle arrest, and apoptosis. Re-expression of miR-101-resistant POMP restores proteasome substrate turnover and tumor cell growth. POMP knockdown also overcomes bortezomib resistance.\",\n      \"method\": \"miRNA target assays, POMP knockdown/rescue experiments, proteasome activity assays, cell cycle and apoptosis assays\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including rescue experiments, published in high-impact journal\",\n      \"pmids\": [\"26145175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Overexpression of hUMP1/POMP in human fibroblasts increases levels of functional proteasome and enhances capacity to cope with oxidative stress, directly linking POMP-mediated proteasome assembly to antioxidant defense.\",\n      \"method\": \"POMP overexpression in primary fibroblasts, proteasome activity assays, oxidative stress survival assays\",\n      \"journal\": \"Experimental gerontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — gain-of-function with defined functional readout, single lab\",\n      \"pmids\": [\"17349762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Heterozygous frameshift variants in the penultimate exon of POMP escape nonsense-mediated mRNA decay, producing a truncated POMP protein that perturbs proteasome assembly by a dominant-negative mechanism, causing an immune dysregulation syndrome (PRAID) with combined immunodeficiency and autoinflammation.\",\n      \"method\": \"Whole-exome sequencing, NMD escape assay, proteasome assembly analysis in patient-derived cells, functional rescue\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — patient mutations with mechanistic validation in patient-derived cells, multiple orthogonal approaches\",\n      \"pmids\": [\"29805043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POMP mutations (compound with MCM3AP mutations) cause defective NF-κB signaling in patient-derived cells; complementation with wild-type POMP rescues defective NF-κB signaling, establishing that intact proteasome assembly via POMP is required for efficient NF-κB signaling.\",\n      \"method\": \"Whole-exome sequencing, complementation assay with WT-POMP in patient cells, NF-κB signaling assays\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — complementation rescue in patient-derived cells, single study\",\n      \"pmids\": [\"26615982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NRF3 transcription factor directly induces POMP gene expression, thereby enhancing 20S proteasome assembly in cancer cells. The NRF3-POMP axis promotes ubiquitin-independent proteolysis of tumor suppressors p53 and Rb by the 20S proteasome, supporting cancer growth.\",\n      \"method\": \"ChIP/transcriptional reporter assays, POMP knockdown, proteasome assembly assays, protein stability assays with proteasome inhibitors (bortezomib, TAK-243), tumor xenograft models\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including in vivo xenograft and mechanistic drug comparison\",\n      \"pmids\": [\"32123008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"POMP is overexpressed in psoriatic lesional skin and binds to 20S precursor complexes; POMP silencing in HaCaT keratinocytes inhibits proteasome assembly, reduces proliferation, induces apoptosis, and decreases differentiation markers (keratin 10, involucrin), establishing POMP's role in keratinocyte proliferation and differentiation.\",\n      \"method\": \"Native gel electrophoresis (proteasome assembly), western blot, IHC, siRNA knockdown in HaCaT cells, differentiation assays\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean KD with multiple functional readouts, direct biochemical binding demonstrated\",\n      \"pmids\": [\"28728908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"POMP forms apparent tetramers in solution (eluting at ~64 kDa by gel filtration) and localizes to both cytoplasm and nucleus, as determined by gel filtration chromatography and immunofluorescence confocal microscopy.\",\n      \"method\": \"Gel filtration chromatography, immunofluorescence, confocal microscopy\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 — single method for oligomerization, localization without functional consequence established\",\n      \"pmids\": [\"16624403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"In yeast, the N-terminal domain of Ump1 (POMP orthologue) directly interacts with the propeptide of the beta7 subunit, promoting recruitment of beta7 precursor into half-proteasome complexes and driving their dimerization into 20S proteasomes. Deletion of the first 16 Ump1 residues massively accumulates 15S precursor complexes and distinct intermediates.\",\n      \"method\": \"In vitro pulldown of Ump1 N-terminal domain with beta7 propeptide, genetic deletion/mutation analysis, growth phenotype assays, genetic suppression by beta7 overexpression\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro direct interaction combined with genetic epistasis, single lab\",\n      \"pmids\": [\"35204754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Yeast Ump1 (POMP orthologue) is an intrinsically disordered protein in solution, as shown by NMR backbone chemical shift analysis, suggesting it may become structured only upon interaction with proteasome subunits.\",\n      \"method\": \"NMR spectroscopy (backbone chemical shift assignment), bioinformatic disorder prediction\",\n      \"journal\": \"Biomolecular NMR assignments\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — direct structural characterization by NMR, single lab\",\n      \"pmids\": [\"24065419\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Recombinant yeast Ump1 purifies as a mixture of oligomeric species; oligomerization is mediated by intermolecular disulfide bonds through its single cysteine residue. Biochemical and biophysical analysis confirms Ump1 has characteristics of an intrinsically disordered protein.\",\n      \"method\": \"Recombinant protein expression and purification, gel filtration, biophysical assays, disulfide bond analysis by mutagenesis\",\n      \"journal\": \"Computational and structural biotechnology journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution and biophysical characterization, single lab\",\n      \"pmids\": [\"24688736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structures of chaperone-bound human 20S proteasome assembly intermediates reveal that PAC1-4 stabilize an early alpha-ring intermediate; PAC3/PAC4 dissociate to allow beta-ring assembly; rearrangement of PAC1 N-terminal tail accompanies this transition. Completion of the beta-ring and half-proteasome dimerization repositions lysine K33 to trigger cleavage of beta propeptides, leading to concerted dissociation of POMP and PAC1/PAC2 to yield the mature 20S proteasome.\",\n      \"method\": \"Cryo-EM of CRISPR/Cas9-tagged endogenous chaperone complexes, structural analysis of assembly intermediates\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM structures of endogenous assembly intermediates with mechanistic insight into POMP release\",\n      \"pmids\": [\"bio_10.1101_2024.08.08.607236\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Upon proteasome disruption, POMP rapidly accumulates in the nucleolus in a manner dependent on HSF1 and reactive oxygen species (ROS). Proteomic analysis reveals POMP interacts with RNA processing factors in this context, and transcriptomic profiling shows that nucleolar POMP orchestrates a protective transcriptional program, revealing a moonlighting role for POMP as a stress-induced transcriptional regulator beyond its canonical proteasome assembly chaperone function.\",\n      \"method\": \"Live-cell imaging of POMP relocalization, proteomic interactome analysis, transcriptomic profiling, HSF1/ROS perturbation experiments\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (proteomics, transcriptomics, imaging), preprint not yet peer-reviewed\",\n      \"pmids\": [\"bio_10.1101_2025.04.25.650603\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRISPR-generated pomp mutant zebrafish embryos display defects in myocardial cell shapes and outflow tract development, establishing a critical role for POMP in vertebrate heart development.\",\n      \"method\": \"CRISPR/Cas9 mutagenesis in zebrafish, phenotypic analysis of heart development\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — clean loss-of-function in vertebrate model with defined developmental phenotype, preprint\",\n      \"pmids\": [\"bio_10.1101_2025.01.16.633339\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"POMP (proteasome maturation protein) is an intrinsically disordered assembly chaperone that associates with ER membranes, binds nascent alpha-rings, and recruits beta-subunits stepwise into 20S proteasome precursor complexes; its N-terminal domain directly contacts the beta7 subunit propeptide to drive half-proteasome dimerization, after which POMP is degraded upon autocatalytic activation of the nascent proteasome (a process mechanistically revealed by cryo-EM structures showing that half-proteasome dimerization repositions K33 to trigger beta propeptide cleavage and concerted POMP/PAC1/PAC2 dissociation); beyond assembly, POMP is regulated transcriptionally by NRF3 and post-transcriptionally by miR-101, and upon proteasome stress it moonlights as a nucleolar transcriptional regulator in an HSF1/ROS-dependent manner.\"\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2000,\n      \"finding\": \"POMP (hUmp1) was identified as the human homologue of yeast Ump1 and shown to be present exclusively in 20S proteasome precursor complexes (16S intermediates) but not in mature 20S proteasomes, establishing its role as a transient assembly chaperone. POMP expression is induced by interferon-gamma. The beta5 propeptide is not essential for LMP7 incorporation in human cells (unlike yeast), but its deletion leads to delayed proteasome maturation and accumulation of POMP-containing precursor complexes.\",\n      \"method\": \"2D gel electrophoresis of precursor fractions, Northern blot, mutant LMP7 incorporation assays in T2 cells\",\n      \"journal\": \"Journal of molecular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (2D gel, Northern blot, functional incorporation assays), foundational characterization paper\",\n      \"pmids\": [\"10926487\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"The main steps of mammalian 20S proteasome core complex formation take place at the endoplasmic reticulum (ER). POMP interacts with ER membranes, binds to alpha1-7 rings, recruits beta-subunits stepwise, and mediates the association of precursor complexes with the ER, coordinating the assembly process.\",\n      \"method\": \"Precursor complex-specific antibodies, subcellular fractionation, immunofluorescence, co-immunoprecipitation\",\n      \"journal\": \"EMBO reports\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (antibody-based fractionation, co-IP, localization) establishing ER as site of assembly with mechanistic detail\",\n      \"pmids\": [\"17948026\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"In yeast, beta7 (Pre4) overproduction bypasses the requirement for the beta5 propeptide by a mechanism dependent on a unique beta7 C-terminal extension. Assembly proceeds stepwise through precursor dimers containing the Ump1 assembly factor and a Pba1-Pba2 complex. Ump1 enforces an assembly checkpoint; beta7 addition overcomes this checkpoint and stabilizes the precursor dimer to drive dimerization of two half-proteasomes.\",\n      \"method\": \"Genetic bypass/suppressor analysis, identification of assembly intermediates, biochemical fractionation, yeast genetics\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — genetic epistasis combined with biochemical fractionation of intermediates, highly cited foundational study\",\n      \"pmids\": [\"17431397\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2006,\n      \"finding\": \"POMP protein elutes from a calibrated gel-filtration column at approximately 64 kDa, suggesting tetramer formation. Immunofluorescence and confocal microscopy showed POMP localizes to both cytoplasm and nucleus.\",\n      \"method\": \"Gel filtration chromatography, immunofluorescence, confocal microscopy\",\n      \"journal\": \"International journal of biological macromolecules\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 3 — single lab, biochemical and imaging methods but no functional consequence tied to tetramerization\",\n      \"pmids\": [\"16624403\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"A single-nucleotide deletion at position c.-95 in the POMP 5' UTR causes a transcriptional switch, markedly increasing POMP transcript variants with long 5' UTRs in keratinocytes. This is associated with altered epidermal distribution of POMP, proteasome subunits alpha7 and beta5, and ER stress marker CHOP, causing KLICK genodermatosis. These findings demonstrate a critical role for POMP-mediated proteasome assembly in terminal epidermal differentiation.\",\n      \"method\": \"SNP analysis, sequencing, Northern blot, immunohistochemistry, patient-derived keratinocytes\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — disease-causing mutation with mechanistic characterization via multiple methods in patient material\",\n      \"pmids\": [\"20226437\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"siRNA silencing of POMP in epidermal air-liquid cultures caused aberrant proteasome subunit staining, perturbed profilaggrin-to-filaggrin processing, and activated the unfolded protein response (CHOP induction/ER stress), establishing that POMP is required for proteasome assembly in differentiating keratinocytes and that its loss leads to proteasome insufficiency and ER stress.\",\n      \"method\": \"siRNA knockdown, organotypic culture, immunohistochemistry, Western blot, CHOP induction assay\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods in a disease-relevant in vitro model with defined molecular phenotype\",\n      \"pmids\": [\"22235297\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"Yeast Ump1 is an intrinsically disordered protein (IDP) that lacks stable secondary structure in solution. Recombinant Ump1 forms oligomers mediated by intermolecular disulfide bonds through its single cysteine residue. The disordered nature may allow Ump1 to become structured only upon interaction with proteasome subunits.\",\n      \"method\": \"Recombinant protein expression, gel filtration, NMR, bioinformatics, biochemical analysis\",\n      \"journal\": \"Computational and structural biotechnology journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1-2 — NMR and biochemical characterization, but functional consequence of IDP nature not directly tested\",\n      \"pmids\": [\"24688736\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"miR-101 directly targets POMP, leading to impaired proteasome assembly and activity, accumulation of p53 and CDK inhibitors, cell cycle arrest, and apoptosis. miR-101-resistant POMP restores proteasome substrate turnover and tumor cell growth. POMP knockdown is sufficient to overcome bortezomib resistance in tumor cells, and suppressing POMP attenuates estrogen-driven transcription in ERα-positive breast cancers.\",\n      \"method\": \"miRNA overexpression, POMP knockdown, proteasome activity assays, cell cycle and apoptosis assays, bortezomib resistance rescue experiments\",\n      \"journal\": \"Molecular cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (miRNA targeting, KD, rescue, activity assays) with defined molecular phenotypes in multiple cell lines\",\n      \"pmids\": [\"26145175\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"POMP mutation combined with MCM3AP (GANP) mutation in an immunodeficient patient results in impaired NF-κB signaling after DNA damage. Complementation with wild-type POMP rescued defective NF-κB signaling, establishing that POMP-dependent proteasome assembly is required for efficient DNA damage-induced NF-κB signaling.\",\n      \"method\": \"Whole-exome sequencing, Sanger sequencing, complementation assay with wild-type POMP, patient-derived cell characterization\",\n      \"journal\": \"Human mutation\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — functional complementation in patient cells, but single case/digenic context limits generalizability\",\n      \"pmids\": [\"26615982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"POMP binds to 20S proteasome precursor complexes and is overexpressed in lesional psoriatic skin. POMP silencing in HaCaT keratinocytes inhibited cell proliferation and induced apoptosis through inhibition of proteasome assembly, and also decreased expression of differentiation markers keratin 10 and involucrin during calcium-induced differentiation.\",\n      \"method\": \"Native gel electrophoresis, Western blot, IHC, qPCR, siRNA silencing, cell proliferation and apoptosis assays\",\n      \"journal\": \"Journal of dermatological science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — co-IP/native gel plus functional KD with specific cellular phenotypes in a relevant cell line\",\n      \"pmids\": [\"28728908\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2018,\n      \"finding\": \"Heterozygous frameshift variants in the penultimate exon of POMP escape nonsense-mediated mRNA decay (NMD) and produce a truncated protein that perturbs proteasome assembly by a dominant-negative mechanism, causing PRAID (POMP-related autoinflammation and immune dysregulation disease) with early-onset combined immunodeficiency, inflammatory neutrophilic dermatosis, and autoimmunity.\",\n      \"method\": \"Whole-exome sequencing, NMD assay, proteasome assembly analysis, patient cell characterization, biochemical analysis of truncated protein\",\n      \"journal\": \"American journal of human genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including NMD escape demonstration, proteasome assembly perturbation, and patient phenotyping\",\n      \"pmids\": [\"29805043\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"NRF3 transcription factor directly induces POMP gene expression in cancer cells, upregulating 20S proteasome assembly. The NRF3-POMP axis promotes ubiquitin-independent proteolysis of tumor suppressors p53 and Rb by the 20S proteasome, supporting colorectal cancer development and metastasis, and conferring impaired sensitivity to bortezomib (but not to E1 inhibitor TAK-243).\",\n      \"method\": \"NRF3 knockdown, POMP overexpression/knockdown, reporter assays, protein stability assays with proteasome inhibitors, ChIP, cell viability and tumorigenesis assays\",\n      \"journal\": \"Molecular and cellular biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods establishing transcriptional regulation of POMP by NRF3 and functional consequences for 20S-dependent proteolysis\",\n      \"pmids\": [\"32123008\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"An N-terminal domain of yeast Ump1 (first 16 residues) and the propeptide of beta7 promote direct interaction of the two proteins in vitro. This interaction is critical for recruitment of beta7 precursor during proteasome assembly, a step that drives dimerization of 15S half-proteasome precursor complexes and formation of mature 20S core particles. Deletion of the first 16 Ump1 residues causes accumulation of 15S PC intermediates and requires Rpn4-dependent transcription for viability, which is rescued by beta7 overexpression.\",\n      \"method\": \"In vitro binding assay, mutational analysis of Ump1 and beta7, yeast genetics (epistasis, rescue), native gel analysis of intermediates\",\n      \"journal\": \"Biomolecules\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — in vitro reconstitution of direct binding combined with genetic epistasis and biochemical intermediate analysis\",\n      \"pmids\": [\"35204754\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Upon proteasome disruption, POMP rapidly accumulates in the nucleolus in a manner dependent on HSF1 and reactive oxygen species (ROS). Proteomic analysis reveals POMP interacts with RNA processing factors in this context, and transcriptomic profiling shows nucleolar POMP orchestrates a protective transcriptional program, revealing a moonlighting role as a stress-induced transcriptional regulator beyond its canonical chaperone function. This mechanism is developmentally controlled and active in neurodegenerative disease contexts.\",\n      \"method\": \"Live-cell imaging, proteomic interactor analysis, transcriptomic profiling, HSF1/ROS perturbation experiments\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods (imaging, proteomics, transcriptomics) but preprint with no peer review yet\",\n      \"pmids\": [\"bio_10.1101_2025.04.25.650603\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cryo-EM structural analysis of human 20S proteasome biogenesis revealed: PAC1-4 stabilize an early alpha-ring intermediate; PAC3/PAC4 dissociation and PAC1 N-terminal tail rearrangement trigger beta-ring assembly; completion of the beta-ring and half-proteasome dimerization repositions lysine K33 to trigger cleavage of beta propeptides, leading to concerted dissociation of POMP and PAC1/PAC2 to yield mature 20S proteasomes.\",\n      \"method\": \"CRISPR/Cas9 endogenous tagging of chaperones, cryo-EM structural analysis of chaperone-bound complexes\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1 — cryo-EM with endogenous tagging providing high-resolution structural mechanism, but preprint awaiting peer review\",\n      \"pmids\": [\"bio_10.1101_2024.08.08.607236\"],\n      \"is_preprint\": true\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"Overexpression of hUMP1/POMP in human fibroblasts increases levels of functional proteasome and enhances cellular capacity to cope with oxidative stressors, demonstrating that POMP-mediated proteasome assembly upregulation is sufficient to enhance antioxidant defense.\",\n      \"method\": \"Stable overexpression in fibroblasts, proteasome activity assays, oxidative stress survival assays\",\n      \"journal\": \"Experimental gerontology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — functional overexpression with defined proteasome activity and stress-resistance phenotype in human cells\",\n      \"pmids\": [\"17349762\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"CRISPR-generated pomp mutant zebrafish embryos display defects in myocardial cell shapes and outflow tract development, establishing a critical role for POMP in heart development. These cardiac phenotypes resemble those of other zebrafish congenital heart defect gene mutants.\",\n      \"method\": \"CRISPR mutagenesis in zebrafish, phenotypic analysis of heart morphology (myocardial cell shape, outflow tract)\",\n      \"journal\": \"bioRxiv\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — CRISPR loss-of-function in a vertebrate model organism with specific cardiac phenotype readout, but preprint\",\n      \"pmids\": [\"bio_10.1101_2025.01.16.633339\"],\n      \"is_preprint\": true\n    }\n  ],\n  \"current_model\": \"POMP (proteasome maturation protein, human homologue of yeast Ump1) is a transiently acting, intrinsically disordered assembly chaperone that binds alpha-rings at the endoplasmic reticulum, recruits beta-subunits stepwise into 15S half-proteasome precursor complexes, directly interacts via its N-terminal domain with the beta7 propeptide to drive half-proteasome dimerization, and is then degraded upon autocatalytic activation of the nascent 20S core; its expression is induced by interferon-gamma and the transcription factor NRF3, regulated post-transcriptionally by miR-101, and loss-of-function or dominant-negative mutations cause proteasome insufficiency linked to skin disorders (KLICK), autoinflammatory immunodeficiency (PRAID), and impaired NF-κB signaling, while a newly discovered moonlighting role involves stress-induced nucleolar accumulation where POMP orchestrates a protective transcriptional program via HSF1 and ROS-dependent mechanisms.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"POMP is the principal assembly chaperone of the 20S proteasome, guiding stepwise incorporation of beta-subunits onto alpha-rings at the endoplasmic reticulum and promoting half-proteasome dimerization through a direct interaction between its N-terminal domain and the beta7 subunit propeptide, after which POMP is degraded by the newly activated proteasome [PMID:10926487, PMID:17948026, PMID:35204754]. POMP is an intrinsically disordered protein whose abundance is transcriptionally controlled by NRF3 and post-transcriptionally by miR-101; loss of POMP impairs proteasome capacity, stabilizes tumor suppressors p53 and Rb, triggers ER stress and the unfolded protein response, and can overcome bortezomib resistance [PMID:24065419, PMID:32123008, PMID:26145175, PMID:22235297]. Heterozygous frameshift mutations producing a dominant-negative truncated POMP cause PRAID, an immune dysregulation syndrome combining immunodeficiency and autoinflammation, while a 5′ UTR deletion underlies KLICK genodermatosis through disrupted epidermal proteasome biogenesis [PMID:29805043, PMID:20226437]. Upon proteasome stress, POMP accumulates in the nucleolus in an HSF1/ROS-dependent manner and orchestrates a protective transcriptional program, revealing a moonlighting role beyond proteasome assembly [PMID:bio_10.1101_2025.04.25.650603].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Establishing that POMP is an assembly-specific chaperone answered the fundamental question of how mammalian 20S proteasome biogenesis is orchestrated: POMP is present only in precursor complexes and is degraded upon maturation, defining it as a dedicated, consumed assembly factor.\",\n      \"evidence\": \"2D gel analysis of 16S precursor preparations and mutant LMP7 incorporation assays in human T2 cells\",\n      \"pmids\": [\"10926487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism of POMP degradation upon maturation was unknown\", \"Subcellular site of assembly was undefined\", \"Precise order of beta-subunit incorporation was not resolved\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Determining that POMP operates at the ER and that yeast Ump1 enforces a dimerization checkpoint resolved where and how assembly is coordinated: POMP binds alpha-rings at ER membranes and recruits beta-subunits stepwise, while Ump1/POMP gates the critical half-proteasome dimerization step that can be bypassed by beta7 overexpression.\",\n      \"evidence\": \"Subcellular fractionation, co-immunoprecipitation and live-cell imaging in mammalian cells; genetic bypass suppressor analysis and intermediate isolation in yeast\",\n      \"pmids\": [\"17948026\", \"17431397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct physical contact between POMP and specific beta-subunits was not mapped\", \"Whether ER association was integral or peripheral was unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Demonstrating that POMP overexpression increases functional proteasome levels and oxidative stress resistance established that POMP is rate-limiting for proteasome biogenesis and linked proteasome capacity to cellular stress defense.\",\n      \"evidence\": \"POMP overexpression in primary human fibroblasts with proteasome activity and oxidative stress survival assays\",\n      \"pmids\": [\"17349762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Mechanism by which increased proteasome levels enhance oxidative defense was not delineated\", \"Whether endogenous POMP fluctuation controls proteasome levels physiologically was not tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Identifying a POMP 5′ UTR deletion as the cause of KLICK genodermatosis answered whether POMP dysfunction causes human disease: aberrant POMP transcript usage disrupts epidermal proteasome distribution and triggers ER stress in terminally differentiating keratinocytes.\",\n      \"evidence\": \"SNP mapping, Sanger sequencing, immunohistochemistry of patient skin biopsies\",\n      \"pmids\": [\"20226437\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Exact mechanism by which longer transcripts reduce POMP protein was not fully defined\", \"No rescue experiment in patient cells\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"siRNA knockdown of POMP in organotypic skin cultures demonstrated that POMP-dependent proteasome assembly is required for profilaggrin processing and keratinocyte differentiation, and that its loss activates the unfolded protein response.\",\n      \"evidence\": \"siRNA knockdown in air-liquid interface organotypic cultures, western blot, UPR marker analysis\",\n      \"pmids\": [\"22235297\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether POMP loss phenocopies KLICK in this model was not explicitly tested\", \"Other proteasome chaperone contributions were not dissected\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"NMR and biophysical characterization established that POMP/Ump1 is intrinsically disordered in isolation, resolving the structural basis for its chaperone function: POMP likely folds only upon engaging proteasome subunits.\",\n      \"evidence\": \"NMR backbone chemical shift analysis, gel filtration, disulfide bond mutagenesis of recombinant yeast Ump1\",\n      \"pmids\": [\"24065419\", \"24688736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Structure of POMP within the precursor complex was not determined\", \"Whether disorder is functionally required was not tested by structured-replacement experiments\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Discovery of miR-101 as a direct post-transcriptional repressor of POMP, and demonstration that POMP loss phenocopies proteasome inhibition (p53/CDK inhibitor accumulation, cell cycle arrest, apoptosis, bortezomib resistance overcome), established POMP as a druggable node in cancer proteasome biology.\",\n      \"evidence\": \"miRNA target assays, POMP knockdown/rescue experiments, proteasome activity assays, cell cycle and apoptosis assays\",\n      \"pmids\": [\"26145175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo anti-tumor efficacy of POMP targeting was not shown\", \"Whether miR-101 regulation is tissue-specific was not explored\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Identification of dominant-negative POMP frameshift mutations escaping NMD as the cause of PRAID syndrome resolved how partial proteasome assembly deficiency drives combined immunodeficiency and autoinflammation in humans.\",\n      \"evidence\": \"Whole-exome sequencing, NMD escape assay, proteasome assembly analysis and functional rescue in patient-derived cells\",\n      \"pmids\": [\"29805043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific immune cell populations most affected were not fully characterized\", \"Whether therapeutic proteasome augmentation could rescue PRAID was untested\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"Showing that NRF3 directly activates POMP transcription to promote 20S assembly and ubiquitin-independent degradation of p53 and Rb established a cancer-promoting transcriptional axis controlling proteasome biogenesis.\",\n      \"evidence\": \"ChIP/reporter assays, proteasome assembly assays, protein stability assays with proteasome inhibitors, tumor xenograft models\",\n      \"pmids\": [\"32123008\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF3-POMP axis operates in non-cancer contexts was not examined\", \"Structural basis for 20S-mediated ubiquitin-independent degradation via POMP was not resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"Mapping the direct interaction between the Ump1/POMP N-terminal domain and the beta7 propeptide resolved the molecular trigger for half-proteasome dimerization: POMP physically recruits the final beta-subunit whose incorporation licenses the dimerization checkpoint.\",\n      \"evidence\": \"In vitro pulldown of Ump1 N-terminal domain with beta7 propeptide, genetic deletion and suppression by beta7 overexpression in yeast\",\n      \"pmids\": [\"35204754\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether the same N-terminal interaction occurs in human POMP was not directly shown\", \"Binding affinity and stoichiometry were not quantified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Cryo-EM structures of human proteasome assembly intermediates revealed the structural mechanism of POMP release: half-proteasome dimerization repositions K33, triggering beta propeptide cleavage and concerted dissociation of POMP and PAC1/PAC2 to yield the mature 20S particle.\",\n      \"evidence\": \"(preprint) Cryo-EM of CRISPR/Cas9-tagged endogenous chaperone complexes\",\n      \"pmids\": [\"bio_10.1101_2024.08.08.607236\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Peer review pending\", \"Dynamics of POMP degradation after release were not captured\", \"Whether POMP release is coupled to ER detachment was not addressed\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Discovery that POMP accumulates in the nucleolus upon proteasome stress in an HSF1/ROS-dependent manner and drives a protective transcriptional program revealed a moonlighting function entirely distinct from proteasome assembly.\",\n      \"evidence\": \"(preprint) Live-cell imaging, proteomic interactome analysis, transcriptomic profiling, HSF1/ROS perturbation experiments\",\n      \"pmids\": [\"bio_10.1101_2025.04.25.650603\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Peer review pending\", \"Mechanism by which a disordered protein regulates transcription is unresolved\", \"Whether nucleolar POMP function is conserved beyond human cells is unknown\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the high-resolution structure of human POMP within precursor complexes, the mechanism by which POMP transitions from assembly chaperone to nucleolar transcriptional regulator, and whether POMP can be therapeutically targeted to modulate proteasome output in cancer or proteasome-associated autoinflammatory diseases.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No high-resolution structure of human POMP bound within the half-proteasome\", \"Molecular basis of nucleolar transcriptional activity unknown\", \"No therapeutic strategies targeting POMP have been validated in vivo\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 2, 12]},\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [2]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [2, 11]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [11]},\n      {\"term_id\": \"GO:0005730\", \"supporting_discovery_ids\": [16]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 5, 12, 15]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [6, 16]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [7, 8]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [7, 3]}\n    ],\n    \"complexes\": [\n      \"20S proteasome precursor complex (half-proteasome)\"\n    ],\n    \"partners\": [\n      \"PSMB7\",\n      \"PSMB5\",\n      \"PAC1\",\n      \"PAC2\",\n      \"NRF3\",\n      \"HSF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```\n\n--- ROUND 2 (R2/R3, augmented corpus) ---\n\n```json\n{\n  \"mechanistic_narrative\": \"POMP is an intrinsically disordered, transiently acting assembly chaperone essential for biogenesis of the 20S proteasome core particle. It associates with alpha-rings at the endoplasmic reticulum, recruits beta-subunits stepwise into half-proteasome precursor complexes, and directly engages the beta7 propeptide via its N-terminal domain to drive half-proteasome dimerization, after which it is degraded upon autocatalytic maturation of the nascent 20S particle [PMID:10926487, PMID:17948026, PMID:35204754]. Its expression is induced by interferon-gamma and the transcription factor NRF3, and is post-transcriptionally repressed by miR-101; loss of POMP causes proteasome insufficiency, ER stress, and impaired NF-κB signaling, while dominant-negative truncating variants escaping NMD cause PRAID (POMP-related autoinflammation and immune dysregulation) and a 5′ UTR mutation causes the keratinization disorder KLICK [PMID:20226437, PMID:29805043, PMID:26145175, PMID:32123008]. POMP overexpression is sufficient to increase functional proteasome levels and enhance cellular resistance to oxidative stress [PMID:17349762].\",\n  \"teleology\": [\n    {\n      \"year\": 2000,\n      \"claim\": \"Identification of POMP as the human Ump1 orthologue present exclusively in proteasome precursor complexes established that 20S assembly requires a dedicated, transient chaperone induced by interferon-gamma.\",\n      \"evidence\": \"2D gel electrophoresis of precursor fractions, Northern blot, and mutant LMP7 incorporation assays in T2 cells\",\n      \"pmids\": [\"10926487\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of POMP–precursor interaction unknown\", \"Subcellular site of assembly not determined\", \"Mechanism of POMP degradation upon maturation unclear\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Localization of proteasome assembly to the endoplasmic reticulum resolved where POMP orchestrates the stepwise recruitment of beta-subunits onto alpha-rings, and yeast genetics revealed that Ump1 enforces an assembly checkpoint overcome by beta7 addition to drive half-proteasome dimerization.\",\n      \"evidence\": \"Subcellular fractionation, co-IP, and immunofluorescence in mammalian cells; genetic bypass/suppressor analysis and biochemical fractionation of assembly intermediates in yeast\",\n      \"pmids\": [\"17948026\", \"17431397\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct POMP–beta7 interaction not demonstrated in vitro\", \"Structural intermediates not resolved at high resolution\", \"Role of PAC1-4 co-chaperones in relation to POMP not fully delineated\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Overexpression of POMP in human fibroblasts proved sufficient to increase functional proteasome levels and enhance resistance to oxidative stress, establishing POMP as a rate-limiting factor in proteasome biogenesis with physiological consequences.\",\n      \"evidence\": \"Stable overexpression, proteasome activity assays, and oxidative stress survival assays in human fibroblasts\",\n      \"pmids\": [\"17349762\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Whether endogenous POMP levels are limiting in vivo not addressed\", \"No in vivo animal model tested\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Discovery that a 5′ UTR mutation in POMP causes KLICK genodermatosis linked proteasome assembly deficiency to a human Mendelian skin disease and revealed the sensitivity of terminal epidermal differentiation to POMP dosage.\",\n      \"evidence\": \"SNP analysis, Northern blot, immunohistochemistry, and analysis of patient-derived keratinocytes\",\n      \"pmids\": [\"20226437\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Precise mechanism by which 5′ UTR shift reduces functional POMP protein not fully resolved\", \"No rescue experiment in patient cells reported\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"siRNA silencing of POMP in organotypic epidermal cultures demonstrated that loss of proteasome assembly causes ER stress, defective profilaggrin processing, and unfolded protein response activation, providing a mechanistic basis for KLICK pathology.\",\n      \"evidence\": \"siRNA knockdown in air-liquid interface keratinocyte cultures, immunohistochemistry, Western blot, CHOP induction assay\",\n      \"pmids\": [\"22235297\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Specific proteasome substrates accumulating in POMP-deficient epidermis not catalogued\", \"Contribution of immunoproteasome versus constitutive proteasome not distinguished\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Biophysical characterization of yeast Ump1 as an intrinsically disordered protein suggested that POMP-family chaperones acquire structure only upon engagement with proteasome subunits, rationalizing their transient incorporation.\",\n      \"evidence\": \"Recombinant protein NMR, gel filtration, and bioinformatics\",\n      \"pmids\": [\"24688736\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No direct evidence that human POMP is similarly disordered\", \"Functional consequence of IDP nature not tested by mutagenesis\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Identification of miR-101 as a direct post-transcriptional repressor of POMP revealed that POMP levels are rate-limiting for tumor cell proteasome capacity, and that POMP knockdown is sufficient to overcome bortezomib resistance.\",\n      \"evidence\": \"miRNA overexpression, POMP knockdown and miR-101-resistant rescue, proteasome activity assays, bortezomib resistance experiments in multiple cell lines\",\n      \"pmids\": [\"26145175\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of miR-101–POMP axis in tumors not demonstrated\", \"Whether other miRNAs converge on POMP not explored\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"A patient POMP mutation combined with MCM3AP deficiency showed that POMP-dependent proteasome assembly is required for DNA damage-induced NF-κB signaling, extending POMP's functional reach beyond proteostasis to immune signaling.\",\n      \"evidence\": \"Whole-exome sequencing, complementation with wild-type POMP in patient-derived cells\",\n      \"pmids\": [\"26615982\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Digenic context complicates attribution of phenotype to POMP alone\", \"Single patient—generalizability uncertain\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"Dominant-negative POMP frameshift variants that escape NMD were shown to poison proteasome assembly, causing PRAID—a syndromic autoinflammatory immunodeficiency—demonstrating that truncated POMP actively disrupts the assembly pathway.\",\n      \"evidence\": \"Whole-exome sequencing, NMD escape assay, proteasome assembly analysis, patient cell characterization\",\n      \"pmids\": [\"29805043\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Structural basis of dominant-negative interference not determined\", \"Whether haploinsufficiency alone is pathogenic not resolved\"]\n    },\n    {\n      \"year\": 2020,\n      \"claim\": \"NRF3 was identified as a direct transcriptional activator of POMP in cancer cells, showing that the NRF3–POMP axis promotes ubiquitin-independent 20S-mediated degradation of p53 and Rb to drive colorectal tumorigenesis.\",\n      \"evidence\": \"ChIP, reporter assays, knockdown/overexpression, protein stability assays with proteasome and E1 inhibitors, tumorigenesis assays\",\n      \"pmids\": [\"32123008\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether NRF3–POMP axis operates in non-cancer tissues not addressed\", \"Structural selectivity of 20S for disordered tumor suppressors not mechanistically resolved\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"In vitro reconstitution demonstrated that the N-terminal 16 residues of Ump1 directly bind the beta7 propeptide, identifying the minimal interaction that triggers half-proteasome dimerization and providing the first direct binding evidence for this critical assembly step.\",\n      \"evidence\": \"In vitro binding assays, Ump1 and beta7 deletion mutants, yeast genetic rescue, native gel analysis of assembly intermediates\",\n      \"pmids\": [\"35204754\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No equivalent binding data for human POMP–beta7\", \"Atomic-resolution structure of the POMP–beta7 interface lacking\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Key open questions include the high-resolution structural basis of POMP within mammalian half-proteasome precursors, the mechanism of its concerted degradation upon 20S maturation, in vivo validation of its reported nucleolar stress-sensing role, and whether its cardiac developmental function reflects proteasome-dependent or moonlighting activity.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No published atomic-resolution structure of human POMP bound to assembly intermediates (cryo-EM preprint awaits peer review)\", \"Mechanism of POMP degradation upon 20S maturation not reconstituted\", \"Nucleolar moonlighting role reported only in a preprint\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0044183\", \"supporting_discovery_ids\": [0, 1, 2, 6, 12]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [0, 2, 12]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005783\", \"supporting_discovery_ids\": [1]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [3]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [3]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-392499\", \"supporting_discovery_ids\": [0, 1, 2, 5, 12]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [5, 15]},\n      {\"term_id\": \"R-HSA-168256\", \"supporting_discovery_ids\": [8, 10]},\n      {\"term_id\": \"R-HSA-1643685\", \"supporting_discovery_ids\": [4, 10]}\n    ],\n    \"complexes\": [\n      \"15S half-proteasome precursor complex\",\n      \"20S proteasome precursor (16S intermediate)\"\n    ],\n    \"partners\": [\n      \"PSMA7\",\n      \"PSMB5\",\n      \"PSMB7\",\n      \"PAC1\",\n      \"PAC2\",\n      \"NRF3\",\n      \"HSF1\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}